Personalized Chemotherapy for Children with Advanced Soft Tissue Tumors
Part of Cancer clinical trials.
This trial uses lab-grown tumor samples from your child to test which chemotherapy drugs work best for their specific cancer. The goal is to find the most effective treatment by testing medicines on their tumor cells before giving them to your child.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child is between 1 and 18 years old
- Your child has been diagnosed with rhabdomyosarcoma, Ewing sarcoma, malignant rhabdoid tumor, or another soft tissue sarcoma
- Your child has already received at least one round of chemotherapy and the cancer came back or got worse
- Your child's doctor can obtain a tissue sample (biopsy) from the tumor
- Your child is in good enough health to handle treatment (ECOG score 0–1) and expected to live at least 6 more months
- Your child's blood counts, liver, and kidney function are adequate for safety
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether giving radiation, chemotherapy, and immunotherapy together can control high-risk soft tissue sarcoma that is hard to remove or may come back after surgery. It may help by attacking cancer in different ways, including boosting the immune system.
This trial tests a combination of three drugs (liposomal irinotecan, temozolomide, and bevacizumab) for people with advanced soft tissue sarcoma that has spread or cannot be removed by surgery. The goal is to see if this combination can help when other treatments have stopped working.
This trial is testing whether a combination of two drugs—a targeted therapy (surufatinib) and an immunotherapy (envafolimab)—can help people with advanced soft tissue sarcoma that has spread or cannot be removed by surgery. Researchers will also use a person's genetic information and scans to see if they can predict who will benefit the most.
This trial tests whether adding immunotherapy (a treatment that helps your immune system fight cancer) to chemotherapy can help young people whose bone or soft tissue sarcoma has come back or hasn't responded to previous treatment.
This trial tests a new immunotherapy drug (envafolimab) combined with two chemotherapy drugs (doxorubicin and ifosfamide) for people with advanced soft tissue sarcoma who have not had prior treatment. The goal is to see if this combination is safe and effective.
This trial tests a combination of chemotherapy, radiation, and two newer drugs (anlotinib and bempegaldesleukin) for people with advanced soft tissue sarcoma that cannot be removed by surgery. The goal is to see if this combination can shrink tumors or slow the cancer's growth.
Hear when a new Soft Tissue Sarcoma, Child trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.